Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
STOCKHOLM — September 15, 2026. Umecrine Cognition today announced that the last patient has completed the final follow-up visit in the company's Phase 1b/2a study of golexanolone in patients with primary biliary cholangitis (PBC). The study evaluates the effect of golexanolone on fatigue and cogni…
STOCKHOLM, Sweden, September 15, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that its portfolio company Umecrine Cognition has reported that the last patient has completed the final follow-up visit in the company’s Phase 1b/2a study of golexanolone in patients with primary biliary c…